Compare BioNTech SE - ADR (BNTX) vs iShares MSCI Australia ETF (EWA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs iShares MSCI Australia ETF — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while iShares MSCI Australia ETF trades at $30.23. The key difference: iShares MSCI Australia ETF is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | EWA | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $119.34 | $30.41 |
52-Week Low | $83.89 | $24.95 |
Enterprise Value | $6.60B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About iShares MSCI Australia ETF
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →
